High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease

Journal of Dermatological Science

Volumn 50, Issue 3, 2008, Pages 177-184

  Aoyagi, Satoru ^a   Akiyama, Masashi ^a   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclin D1; In situ; Invasive carcinoma; Ki 67; Malignancy; Paget's disease

Indexed keywords

ANTIBODY; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; KI 67 ANTIGEN; PARAFFIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER INVASION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PAGET SKIN DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK; TUMOR CELL;

AGED; AGED, 80 AND OVER; AXILLA; CELL DIVISION; CYCLINS; FEMALE; GENITAL NEOPLASMS, MALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PAGET'S DISEASE, EXTRAMAMMARY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SCROTUM; TUMOR MARKERS, BIOLOGICAL; VULVA; VULVAR NEOPLASMS;

EID: 42649134438     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.12.002     Document Type: Article

References (31)

1. Kanitakis J. Mammary and extramammary Paget's disease. J Eur Acad Dermatol Venereol 21 (2007) 581-590
2. Zollo J.D., and Zeitouni N.C. The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol 142 (2000) 59-65
3. Evans A.T., and Neven P. Invasive adenocarcinoma arising in extramammary Paget's disease of the vulva. Histopathology 18 (1991) 355-360
4. Murata Y., Kumano K., and Tani M. Underpants-pattern erythema: a previously unrecognized cutaneous manifestation of extramammary Paget's disease of the genitalia with advanced metastatic spread. J Am Acad Dermatol 40 (1999) 949-956
5. Batinac T., Zamolo G., Coklo M., Hadzisejdic I., Stemberger C., and Zauhar G. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. Pathol Res Pract 202 (2006) 599-607
6. Lebeau S., Masouve I., Berti M., Auqsburger E., Saurat J.H., Borradori L., et al. Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas. Br J Dermatol 152 (2005) 1248-1255
7. Liang S.B., Furihata M., Takeuchi T., Iwata J., Chen B.K., Sonobe H., et al. Overexpression of cyclin D1 in nonmelanocytic skin cancer. Virchows Arch 436 (2000) 370-376
8. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C. p53 mutations in human cancers. Science 253 (1991) 49-53
9. Baker S.J., Markowitz S., Fearon E.R., Willson J.K., and Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249 (1990) 912-915
10. Sliutz G., Schmidt W., Tempfer C., Speiser P., Gitsch G., Eder S., et al. Detection of p53 point mutations in primary human vulvar cancer by PCR and temperature gradient gel electrophoresis. Gynecol Oncol 64 (1997) 93-98
11. Hietanen S.H., Kurvinen K., Syrjänen K., Grénman S., Carey T., McClatchey K., et al. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Am J Obstet Gynecol 173 (1995) 1477-1482
12. Hynes N.E., and stern D.F. The biology of erbB-2/neu/her-2 and its role in cancer. Biochim Biophys Acta 1198 (1994) 165-184
13. Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 78 (2000) 31-101
14. Olayioye M.A., Neve R.M., Lane H.A., and Hynes N.E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19 (2000) 3159-3167
15. Slamon D.J., Clark G.M., Wong S.G., and Levin W.J. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
16. Dowsett M., Bartlett J., Ellis I.O., Salter J., Hills M., Mallon E., et al. Correlation between immunohistochemistry (Hercep Test) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centers. J Pathol 199 (2003) 418-423
17. Hunter T., and pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79 (1994) 573-582
18. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1 (1990) 199-206
19. Isola J.J., Helin H.J., Helle M.J., and Kallioniemi O.P. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count. Cancer 65 (1990) 1180-1184
20. Bouzubar N., Walker K.J., Griffiths K., Ellis I.O., Elston C.W., Robertson J.F., et al. Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59 (1989) 943-947
21. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., and Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 (1990) 334-336
22. Lin N., Uchi H., Moroi Y., Fukiwake N., Dainichi T., Takeuchi S., et al. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease. J Dermatol Sci 45 (2007) 187-192
23. Ellis P.E., Fong L.F., Rolfe K.J., Crow J.C., Reid W.M., Davidson T., et al. The role of p53 and Ki67 in Paget's disease of the vulva and the breast. Gynecol Oncol 86 (2002) 150-156
24. Takata M., Fujimoto A., Aoki H., Hatta N., Ooi A., and Takehara K. erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget's disease. J Invest Dermatol 113 (1999) 258-262
25. Meissner K., Rivière A., Haupt G., and Löning T. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Am J Pathol 137 (1990) 1305-1309
26. Brummer O., Stegner H.E., Böhmer G., Kühnle H., and Petry K.U. HER-2/neu expression in Paget disease of the vulva and the female breast. Gynecol Oncol 95 (2004) 336-340
27. Kanitakis J., Thivolet J., and Claudy A. p53 protein expression in mammary and extramammary Paget's disease. Anticancer Res 13 (1993) 2429-2433
28. Zhang C., Zhang P., Sung C.J., and Lawrence W.D. Overexpression of p53 is correlated with stromal invasion in extramammary Paget's disease of the vulva. Hum Pathol 34 (2003) 880-885
29. Fu W., Lobocki C.A., Silberberg B.K., Chelladurai M., and Young S.C. Molecular markers in Paget disease of the breast. J Surg Oncol 77 (2001) 171-178
30. Joensuu H., Pylkkanen L., and Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145 (1994) 1191-1198
31. Bozzetti C., Nizzoli R., Naldi N., Guazzi A., Camisa R., Bella M.A., et al. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: correlation with other biologic factors. Cancer 87 (1999) 224-230